Literature DB >> 8267420

Initial experience with video-assisted thoracoscopic lobectomy.

T J Kirby1, M J Mack, R J Landreneau, T W Rice.   

Abstract

In the past 2 years, the development of video-assisted thoracic surgery (VATS) has allowed thoracoscopy to rapidly evolve from a primarily diagnostic tool to a therapeutic tool with potentially useful applications. As with laparoscopy, the initial enthusiasm for VATS must be tempered by the reality of technical inadequacies, complications, and results that have yet to withstand careful scientific scrutiny. The purpose of this study was to determine the technical feasibility of a VATS lobectomy. Forty-four patients with primary bronchogenic carcinoma were evaluated and accepted as potential candidates for VATS lobectomy. After complete preoperative staging, these patients were in clinical stage I. All patients had normal arterial blood gases and adequate pulmonary function (forced expiratory volume in 1 second > 1.5 L) to tolerate a lobectomy. At the time of operation, 3 patients were found to have N2 disease and were excluded from the study. In 35 of the remaining 41 patients, a successful VATS lobectomy was accomplished through two thoracoscopy ports and a non-rib-spreading 6- to 8-cm "access" thoracotomy. There were no major intraoperative complications that necessitated conversion to an open thoracotomy. Mean operative time was 153 +/- 26 minutes. All 35 patients recovered uneventfully with a mean hospital stay of 5.7 +/- 1.6 days. A VATS lobectomy is technically feasible using our approach and is potentially safe. However, major advances in thoracoscopy imaging and instrumentation are necessary before this procedure will have the potential for widespread acceptance. Also, the advantages of VATS lobectomy over accepted surgical techniques will have to be carefully documented in randomized trials.

Entities:  

Mesh:

Year:  1993        PMID: 8267420     DOI: 10.1016/0003-4975(93)90661-z

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  44 in total

1.  Thoracoscopic lobectomy for an infected intrapulmonary bronchogenic cyst.

Authors:  A P Yim; H C Lam; J K Ho
Journal:  Surg Endosc       Date:  1996-04       Impact factor: 4.584

2.  Comparison of acute phase protein and hemodynamic variables in dogs undergoing video-assisted thoracoscopic vs. open pneumonectomy.

Authors:  Hai-Feng Liu; Qing-Ming Ren; Zhi-Bo Wang; Xin Li; Sheng Jiang; Jian-Tao Zhang; Hong-Bin Wang
Journal:  Exp Ther Med       Date:  2017-03-23       Impact factor: 2.447

3.  A decade of robotics in lung cancer surgery.

Authors:  Brian E Louie
Journal:  J Thorac Dis       Date:  2016-12       Impact factor: 2.895

4.  Video-assisted thoracoscopic surgery versus open lobectomy for stage I lung cancer: A meta-analysis of long-term outcomes.

Authors:  Zhengjun Li; Hongxu Liu; LE Li
Journal:  Exp Ther Med       Date:  2012-02-13       Impact factor: 2.447

5.  Video-assisted thoracoscopic surgery for the treatment of mediastinal lymph node tuberculous abscesses.

Authors:  Tao Zuo; Feng-Yun Gong; Bao-Jun Chen; Zheng-Yi Ni; Ding-Yu Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-12-21

6.  Reasons not to perform uniportal VATS lobectomy.

Authors:  Alan D L Sihoe
Journal:  J Thorac Dis       Date:  2016-03       Impact factor: 2.895

7.  Minimally invasive lobectomy for early stage non-small cell lung cancer-it can be done without sacrificing oncologic outcomes.

Authors:  Mark F Berry
Journal:  J Thorac Dis       Date:  2016-08       Impact factor: 2.895

Review 8.  Surgical management of lung cancer.

Authors:  Adam Lackey; Jessica S Donington
Journal:  Semin Intervent Radiol       Date:  2013-06       Impact factor: 1.513

9.  Lobectomy: video-assisted thoracic surgery versus posterolateral thoracotomy.

Authors:  T Ohbuchi; T Morikawa; E Takeuchi; H Kato
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1998-06

10.  Video-assisted thoracic surgery (VATS) for resection of metastatic adenocarcinoma as an acceptable alternative.

Authors:  Marilee Carballo; Mary S Maish; Dawn E Jaroszewski; Amy Yetasook; Karl Bauer; Robert B Cameron; E Carmack Holmes
Journal:  Surg Endosc       Date:  2008-12-31       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.